People on the Move Archives - Page 51 of 149

Revvity, Lilly Partner to Broaden Biotech Access to AI Drug Discovery Models

January 9, 2026

How Industry Trends are Impacting Hiring Decisions and Leadership Strategies in Life Sciences

January 6, 2026

Foray Bioscience Secures First Fabricated Seed Partnership With West Coast Chestnut

January 5, 2026

THIS WEEK'S STORIES

VectorY Therapeutics’ VTx-002 Granted FDA Fast Track Designation for ALS

January 8, 2026

International Institute of New England Honors Alnylam CEO Dr. Yvonne Greenstreet With 2026 Golden Door Award

January 7, 2026

Viz.ai Names Dr. Timothy N. Showalter as Its First Chief Medical Officer

January 6, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

AstraZeneca Names Rick R. Suarez US President and Head of US BioPharmaceuticals Unit

Tubulis Names Charles Fuchs, M.D. as Chief Medical Officer to Lead Clinical Strategy

Charles River Laboratories Names Birgit Girshick as Next CEO as James C. Foster Plans Retirement

Kincell Bio Promotes Larry Pitcher to Chief Executive Officer to Drive Growth in Cell Therapy Manufacturing

SpliceBio Names Don Munoz as Chief Financial Officer

Most Read

Aurora Therapeutics Launches With $16 Million Seed Round to Scale Personalized Gene Editing for Rare Diseases

GC Therapeutics Names Kate Haviland Board Chair, Advances Cell Therapy Pipeline and Platform

MEDIPOST Secures $140 Million to Advance U.S. Phase III Stem Cell Trial

Prolytix Expands Thrombosis and Hemostasis Testing Capabilities With HRL Assay Acquisition

EDITOR PICKS